Dr. Stanley Kawanishi, MD

Dr. Kawanishi practices at Pacific Cardiovascular Associates Medical Group, Inc. in Costa Mesa, California.

Dr. Kawanishi's NPI, 1144288242, was assigned on May 1, 2006. Dr. Kawanishi graduated from University of Missouri School of Medicine in 1981. Dr. Kawanishi's California license number on file is G47724.

Dr. Kawanishi's primary practice is Pacific Cardiovascular Associates Medical Group, Inc., at 3080 Bristol St, Costa Mesa, CA 92626 in Orange County. The practice phone is (714) 445-0220.

Dr. Kawanishi's primary practice is Pacific Cardiovascular Associates Medical Group, Inc. in Costa Mesa, California. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Kawanishi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kawanishi practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kawanishi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kawanishi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kawanishi's licenses on file in 2 states: California and Hawaii.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Kawanishi treats.

CMS data shows 365 Medicare services from Dr. Kawanishi across 5 procedure codes in 2024, for 178 Medicare patients. Medicare paid $32,333 for them. Every service was in an office.

CMS counts 178 Medicare patients who saw Dr. Kawanishi in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kawanishi's median patient age at 73, with 52% women.

In 2024, Dr. Kawanishi wrote 2,600 Medicare Part D claims for 418 patients. 79% of them were for generic drugs. CMS names the drug for 2,393 of them, across 35 drugs with 11 or more claims each, at $507,175 in total drug cost. In 2023, CMS named 2,760 claims across 36 drugs.

Dr. Kawanishi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Kawanishi. Dr. Kawanishi's most frequent co-authors are Milton Rolando Drachenberg, MD, PhD and Rex Jay Winters, MD.

CMS Open Payments shows 481 general payments to Dr. Kawanishi from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,164.

Dmand AI lists 3 awards for Dr. Kawanishi, most recently Super Doc in 2013.

Dr. Kawanishi graduated from University of Missouri School of Medicine in 1981. Dr. Kawanishi is a member of ACC.

Dr. Kawanishi is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.